Cytokine-induced protein kinase B activation and bad phosphorylation do not correlate with cell survival of hemopoietic cells

Journal of Immunology

Volumn 162, Issue 12, 1999, Pages 7002-7009

  Hinton, Heather J ^a   Welham, Melanie J ^a  

^a University of Bath ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE B;

ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GROWTH REGULATION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BCL-ASSOCIATED DEATH PROTEIN; CARRIER PROTEINS; CELL DIVISION; CELL LINE; CELL SURVIVAL; CHROMONES; CYTOKINES; ENZYME ACTIVATION; ENZYME INHIBITORS; HEMATOPOIETIC STEM CELLS; MICE; MORPHOLINES; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; SERINE;

EID: 0033564734     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Vanhaesebroeck, B., R. C. Stein, and M. D. Waterfield. 1996. The study of phosphoinositide 3-kinase function. Cancer Surv. 27:249.
2. Gold, M. R., V. Duronio, S. P. Saxena, J. W. Schrader, and R. Aebersold. 1994. Multiple cytokines activate phosphatidylinositol 3-kinase in hemopoietic cells: association of the enzyme with various tyrosine-phosphorylated proteins. J. Biol. Chem. 269:5403.
3. Vanhaesebroeck, B., M. J. Welham, K. Kotani, R. Stein, P. H. Warne, M. J. Zvelebil, K. Higashi, S. Volinia, J. Downward, and M. D. Waterfield. 1997. p110δ, a novel phosphoinositide 3-kinase in leukocytes. Proc. Natl. Acad. Sci. USA 94:4330.
4. Vanhaesebroeck, B., S. J. Leevers, G. Panayotou, and M. D. Waterfield. 1997. Phosphoinositide 3-kinases: a conserved family of signal transducers. Trends Biochem. Sci 22:267.
5. Chantry, D., A. Vojtek, A. Kashishian, D. A. Holtzman, C. Wood, P. W. Gray, J. A. Cooper, and M. F. Hoekstra. 1997. p110δ, a novel phosphatidylinositol 3-kinase catalytic subunit that associates with p85 and is expressed predominantly in leukocytes. J. Biol. Chem. 272:19236.
6. Kauffmann-Zeh, A., P. Rodriguez-Viciana, E. Ulrich, C. Gilbert, P. Coffer, J. Downward, and G. Evan. 1997. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 385:544.
7. Kennedy, S. G., A. J. Wagner, S. D. Conzen, J. Jordan, A. Bellacosa, P. N. Tsichlis, and N. Hay. 1997. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev. 11:701.
8. Khwaja, A., P. Rodriguez Viciana, S. Wennstrom, P. H. Warne, and J. Downward. 1997. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J. 16:2783.
9. Minshall, C., S. Arkins, G. G. Freund, and K. W. Kelly 1996. Requirement for phosphatidylinositol 3′-kinase to protect hematopoietic progenitors against apoptosis depends upon the extracellular survival factor. J. Immunol. 156:939.
10. Scheid, M. P., R. W. Lauener, and V. Duronio. 1995. Role of phosphatidylinositol 3-OH-kinase activity in the inhibition of apoptosis in hematopoietic-cells: phosphatidylinositol 3-OH-kinase inhibitors reveal a difference in signaling between interleukin-3 and granulocyte-macrophage colony-stimulating factor. Biochem. J. 312:159.
11. Scheid, M. P., and V. Duronio. 1998. Dissociation of cytokine-induced phosphorylation of Bad and activation of PKB/akt: involvement of MEK upstream of Bad phosphorylation. Proc. Natl. Acad. Sci. USA 95:7439.
12. Marte, B. M., and J. Downward. 1997. PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem. Sci. 22:355.
13. Bellacosa, A., J. R. Testa, S. P. Staal, and P. N. Tsichlis. 1991. A retroviral oncogene, Akt, encoding a serine-threonine kinase containing an SH2-like region. Science 254:274.
14. Coffer, P. J., and J. R. Woodgett. 1991. Molecular-cloning and characterization of a novel putative protein-serine kinase related to the cAMP-dependent and protein-kinase-C families. Eur. J. Biochem. 201:475.
15. Franke, T. F., S. I. Yang, T. O. Chan, K. Datta, A. Kazlauskas, D. K. Morrison, D. R. Kaplan, and P. N. Tsichlis. 1995. The protein-kinase encoded by the Akt protooncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81:727.
16. Cross, D. A. E., D. R. Alessi, P. Cohen, M. Andjelkovich, and B. A. Hemmings. 1995. Inhibition of glycogen-synthase kinase-3 by insulin-mediated by protein-kinase-B. Nature 378:785.
17. Kohn, A. D., K. S. Kovacina, and R. A. Roth. 1995. Insulin stimulates the kinase-activity of Rac-Pk, a pleckstrin homology domain-containing Ser/Thr kinase. EMBO J. 14:4288.
18. Burgering, B. M. T., and P. J. Coffer. 1995. Protein-Kinase-B (C-Akt) In phosphatidylinositol-3-OH kinase signal-transduction. Nature 376:599.
19. del Peso, L., M. Gonzalez Garcia, C. Page, R. Herrera, and G. Nunez. 1997. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278:687.
20. Datta, S. R., H. Dudek, X. Tao, S. Masters, H. A. Fu, Y. Gotoh, and M. E. Greenberg. 1997. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231.
21. Songyang, Z., D. Baltimore, L. C. Cantley, D. R. Kaplan, and T. F. Franke. 1997. Interleukin 3-dependent survival by the Akt protein kinase. Proc. Natl. Acad. Sci. USA 94:11345.
22. Kohn, A. D., F. Takeuchi, and R. A. Roth. 1996. Akt, a pleckstrin homology domain-containing kinase, is activated primarily by phosphorylation. J. Biol. Chem. 271:21920.
23. Franke, T. F., D. R. Kaplan, L. C. Cantley, and A. Toker. 1997. Direct regulation of the Akt proto-oncogene product by phosphatidylinosital-3,4-bisphosphate. Science 275:665.
24. Datta, K., A. Bellacosa, T. O. Chan, and P. N. Tsichlis. 1996. Akt is a direct target of the phosphatidylinositol 3-kinase: activation by growth-factors, v-Src and v-Ha-Ras, in Sf9 and mammalian-cells. J. Biol. Chem. 271:30835.
25. Alessi, D. R., M. Andjelkovic, B. Caudwell, P. Cron, N. Morrice, P. Cohen, and B. A. Hemmings. 1996. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15:6541.
26. Alessi, D. R., S. R. James, C. P. Downes, A. B. Holmes, P. R. J. Gaffney, C. B. Reese, and P. Cohen. 1997. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B α. Curr. Biol. 7:261.
27. Chao, D. T., and S. J. Korsmeyer. 1998. BCL-2 family: regulators of cell death. Annu. Rev. Immunol. 16:395.
28. Adams, J. M., and S. Cory. 1998. The Bcl-2 protein family: arbiters of cell survival. Science 281:1322.
29. Ottilie, S., J.-L. Diaz, W. Horne, J. Chang, Y. Wang, G. Wilson, S. Chnag, S. Weeks, L. C. Fritz, and T. Oltersdorf. 1997. Dimerization properties of human BAD. J. Biol. Chem. 272:30866.
30. Kelekar, A., B. S. Chang, J. E. Harlan, S. W. Fesik, and C. B. Thompson. 1997. Bad is a BH3 domain-containing protein that forms an inactivating dimer with Bcl-XL. Mol. Cell. Biol. 17:7040.
31. Zha, J. P., H. Harada, E. Yang, J. Jockel, and S. J. Korsmeyer. 1996. Serine phosphorylation of death agonist Bad in response to survival factor results in binding to 14-3-3 not Bcl-X(L). Cell 87:619.
32. Craddock, B. L., E. A. Orchiston, H. J. Hinton, and M. J. Welham. 1999. Dissociation of apoptosis from proliferation, protein kinase B activation and BAD phosphorylation in interleukin-3-mediated phosphoinositide 3-kinase signaling. J. Biol. Chem. 274:10633.
33. Karasuyama, H., and F. Melchers. 1988. Establishment of mouse-cell lines which constitutively secrete large quantities of interleukin-2, interleukin-3, interleukin-4 or interleukin-5, using modified cDNA expression vectors. Eur. J. Immunol. 18:97.
34. Welham, M. J., and J. W. Schrader. 1992. Steel factor-induced tyrosine phosphorylation in murine mast cells: common elements with IL-3-induced signal transduction pathways. J. Immunol. 149:2772.
35. Welham, M. J., V. Duronio, and J. W. Schrader. 1994. Interleukin-4-dependent proliferation dissociates p44(erk-1 ), p42(erk-2), and p21(ras) activation from cell growth J. Biol. Chem. 269:5865.
36. Nabel, G., S. J. Galli, A. M. Dvorak, H. F. Dvorak, and H. Cantour. 1981. Inducer lymphocytes-T synthesize a factor that stimulates proliferation of cloned mast cells. Nature 291:332.
37. Palacios, R., and M. Steinmetz. 1985. IL-3-dependent mouse clones that express B220 surface antigen, contain Ig genes in germ-line configuration and generate lymphocytes-B in vivo. Cell 41:727.
38. Roehm, N. W., G. H. Rodgers, S. M. Hatfield, and A. L. Glasebrook. 1991. An improved colorimetric assay for cell proliferation and viability utilising the tetrazolium salt XTT. J. Immunol. Methods 142:257.
39. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55.
40. Yao, R., and G. M. Cooper. 1995. Requirement for phosphatidylinositol-3 kinase in prevention of apoptosis by nerve growth factor. Science 267:2003.
41. Kulik, G., A. Klippel, and M. J. Weber. 1997. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol. Cell. Biol. 17:1595.
42. Kulik, G., and M. J. Weber. 1998. Akt-dependent and -independent survival signaling pathways utilized by insulin-like growth factor I. Mol. Cel. Biol. 18:6711.
43. Zamorano, J., H. Y. Wang, L. M. Wang, J. H. Pierce, and A. D. Keegan. 1996. IL-4 protects cells from apoptosis via the insulin-receptor substrate pathway and a 2nd independent signaling pathway. J. Immunol. 157:4926.
44. Zamorano, J., and A. D. Keegan. 1998. Regulation of apoptosis by tyrosine-containing domains of IL-4Rα: Y497 and Y713, but not the STAT6-docking tyrosines, signal protection from apoptosis. J. Immunol. 161:859.
45. Welham, M. J., L. Learmonth, H. Bone, and J. W. Schrader. 1995. Interleukin-13 signal transduction in lymphohemopoietic cells: similarities and differences in signal transduction with interleukin-4 and insulin. J. Biol. Chem. 270:12286.
46. Minshall, C., S. Arkins, J. Straza, J. Conners, R. Dantzer, G. G. Freund, and K. W. Kelley. 1997. IL-4 and insulin-like growth factor-I inhibit the decline in Bcl-2 and promote the survival of IL-3-deprived myeloid progenitors. J. Immunol. 159:1225.
47. Welham, M. J., H. Bone, M. Levings, L. Learmonth, L.-M. Wang, K. B. Leslie, J. H. Pierce, and J. W. Schrader. 1997. Insulin receptor substrate-2 is the major 170-kDa protein phosphorylated on tyrosine in response to cytokines in murine lymphohemopoietic cells. J. Biol. Chem. 272:1377.
48. Welham, M. J., V. Duronio, J. S. Sanghera, S. L. Pelech, and J. W. Schrader. 1992. Multiple hemopoietic growth factors stimulate activation of mitogen-activated protein kinase family members. J. Immunol. 149:1683.